Users and Nonusers of Hospitals

PEDIATRICS ◽  
1973 ◽  
Vol 52 (5) ◽  
pp. 754-756
Author(s):  
Gordon T. Moore

In their article examining the impact of the Rochester Neighborhood Health Center on hospitalization of children, Klein et al.1 demonstrated no overall change in hospital admission rates for the target population, but demonstrate a significant decrease in hospital utilization for the health center users. The fact that health center user rates fell while the nonuser rates rose during the study suggests a methodologic artifact as the cause of their findings. Two possible explanations can explain their observations.

PEDIATRICS ◽  
1973 ◽  
Vol 51 (5) ◽  
pp. 833-839
Author(s):  
Michael Klein ◽  
Klaus Roghmann ◽  
Kenneth Woodward ◽  
Evan Charney

The admission patterns of children to area hospitals was studied. The study design allowed for comparisons between actual users of the health center, nonusers who lived in the target area and a comparison group. During the second year of operation, the admission rate of health center users was only 33 versus 67 per thousand for nonusers and 39 per thousand for the comparison group. Comparing the first two years, hospital days per thousand among users dropped by approximately half. Due to higher admission rates and longer average stays, nonusers had a rate of 2.5 times that of the users for hospital days per thousand. The rate for the comparison group remained constant. Users had fewer admissions for respiratory infectious diseases and more admissions for surgical restorative procedures. These trends were not present for the nonusers or for the comparison group. Despite extensive outreach, physician availability, and the team approach, the health center continued to have a large number of child admissions who reached the hospital without referral (the "leakers").


Author(s):  
Jose Luis Izquierdo ◽  
Carlos Almonacid ◽  
Yolanda Gonzalez ◽  
Carlos Del Rio-Bermudez ◽  
Julio Ancochea ◽  
...  

Background: From the onset of the COVID-19 pandemic, an association between the severity of COVID-19 and the presence of certain medical chronic conditions has been suggested. However, unlike influenza and other viruses, the burden of the disease in patients with asthma has been less evident. Objective: This study aims at a better understanding of the burden of COVID-19 in patients with asthma and the impact of asthma, its related comorbidities, and treatment on the prognosis of COVID-19. Methods: We analyzed clinical data from patients with asthma from January 1st to May 10th, 2020 using big data analytics and artificial intelligence through the SAVANA Manager clinical platform. Results: Out of 71,192 patients with asthma, 1,006 (1.41%) suffered from COVID-19. Compared to asthmatic individuals without COVID-19, patients with asthma and COVID-19 were significantly older (55 vs. 42 years), predominantly female (66% vs. 59%), had higher prevalence of hypertension, dyslipidemias, diabetes, and obesity, and smoked more frequently. Contrarily, allergy-related factors such as rhinitis and eczema were less frequent in asthmatic patients with COVID-19 (P < .001). Higher prevalence of hypertension, dyslipidemia, diabetes, and obesity was also confirmed in those patients with asthma and COVID-19 who required hospital admission. The percentage of individuals using inhaled corticosteroids (ICS) was lower in patients who required hospitalization due to COVID-19, as compared to non-hospitalized patients (48.3% vs. 61.5%; OR: 0.58: 95% CI 0.44-0.77). During the study period, 865 (1.21%) patients with asthma were being treated with biologics. Although these patients showed increased severity and more comorbidities at the ear, nose, and throat (ENT) level, their hospital admission rates due to COVID-19 were relatively low (0.23%). COVID-19 increased inpatient mortality in asthmatic patients (2.29% vs 0.54%; OR 2.29: 95% CI 4.35-6.66). Conclusion: Our results indicate that the number of COVID-19 cases in patients with asthma has been low, although higher than the observed in the general population. Patients with asthma and COVID-19 were older and were at increased risk due to comorbidity-related factors. ICS and biologics are generally safe and may be associated with a protective effect against severe COVID-19 infection.


2020 ◽  
Vol 3 (1) ◽  
pp. 19-25
Author(s):  
Sri Ayatina Hayati ◽  
Aminah Aminah ◽  
Nurul Auliah ◽  
Endang Pratiwi

This study aims to provide training to pre-natal pregnant women by using progressive muscle relaxation training to reduce anxiety in pre-natal pregnant women at the 9 November Banjarmasin Health Center. The objectives of this training include: (1) Providing information about the impact, procedures and elements that pre-delivery pregnant women must know at the 9 November Banjarmasin health center in preparation for the Progressive Muscle Relaxation Training. (2) Providing Progressive Muscle Relaxation Training skills training for pregnant women at the 9 November Banjarmasin health center so that they can apply the movements of the Progressive Muscle Relaxation Training when experiencing pre-birth anxiety. Methods in carrying out activities include the following: (1) Lecture: (2) Training: and (3) Evaluation. The target population in this activity was pregnant women with their first pregnancy at the health center on November 9, Banjarmasin. Judging from the level of effectiveness, progressive muscle relaxation training is effective in reducing anxiety in pre-natal pregnant women at the 9 November Banjarmasin Health Center;  Keywords: Progressive Muscle Relaxation Training, Anxiety, Pregnant Mother


2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
D Trabattoni ◽  
G Teruzzi ◽  
P M Ravagnani ◽  
G Santagostino Baldi ◽  
P Montorsi ◽  
...  

Abstract Introduction Preliminary reports from the early phase of COVID-19 epidemic in Italy reported a dramatic reduction in hospital admission rates for acute coronary syndromes (ACS) coupled with longer times from symptoms onset to hospital presentation. Purpose To assess the impact of COVID-19 on hospital admission rates and ACS patterns, as well as time to presentation and clinical outcomes, following the acute pandemic phase in 2020 compared to previous year. Methods We conducted a single institution retrospective analysis conducted in a cardiovascular hub serving a large metropolitan area in Italy. Number and monthly distribution of hospital admissions for ACS from January 1 to December 31, 2020 were compared to the respective figures in 2019. Baseline clinical features, time from symptoms onset to hospital admission and main clinical outcomes were collected. Results A total of 599 ACS cases were recorded in 2020 vs. 386 cases in 2019, with a net 55% increase. ACS presentation rate in 2020 showed a bimodal pattern, paralleling the most contagious outbreak periods (Figure 1). SARS-CoB-2 nasopharyngeal swab or specific antibody tests were positive in 34 (5.7%) patients. Time from symptoms onset to hospital presentation tended to be longer in 2020 than in 2019, being two-fold longer during the peak epidemic phase (February 21-May 3, 2020; median time 2.0 vs. 5.0 hours, p=0.030). The proportion of late-presenting STEMI (&gt;8 hrs from symptoms onset) was higher in 2020 compared to 2019 (30% vs. 18%, p=0.003),as well as higher was in-hospital mortality (15% in 2020 vs 6% in 2019, p=0.001), partly due to a three-fold increase in cardiogenic shock on ACS presentation. Conclusions ACS admission rate significantly increased during the 2020 COVID-19 epidemic outbreak for several reasons only partially explained by a SARS-CoV-2 infection trigger effect on ACS. Longer presentation times and higher rates of cardiogenic shock and mortality were observed, urging the need health-care systems to keep a high priority on cardiovascular emergencies response networks. FUNDunding Acknowledgement Type of funding sources: None. Figure 1


Sign in / Sign up

Export Citation Format

Share Document